Company: IMNN
Filing Date: 2025-07-14
Form Type: 8-K
Source: 0001641172-25-019541
Chunk: 1

Company: Imunon, Inc.
Filing Date: 2025-07-14
Form: 8-K
Item: Item 3.01
Chunk 1
---
 that it has granted Company’s request for an exception (the “ Exception”)
tailored to the time needed for the Company to regain compliance with the Minimum Bid Price Requirement and the Minimum Stockholders’
Equity Requirement.

Pursuant
to the Exception, the Company is required to provide the Panel with prompt notification of any significant events that occur, including
any event that may call into question the Company’s ability to satisfy the terms of the Exception.

There
can be no assurance that the Company will be able to regain compliance with the Minimum Bid Price Requirement or will otherwise be in
compliance with other applicable Nasdaq listing rules or that the Company will be able to successfully implement a reverse stock split
if it decides to pursue one.

If
the Company’s securities are delisted from Nasdaq, it could be more difficult to buy or sell the Company’s common stock or
to obtain accurate quotations, and the price of the Company’s common stock could suffer a material decline. Delisting could also
impair the Company’s ability to raise capital and/or trigger defaults and penalties under outstanding agreements or securities
of the Company.

Except
for the factual statements made herein, information contained in this report consists of forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995 that involve risks, uncertainties and assumptions that are difficult to predict,
including statements regarding the Company’s ability to regain compliance with Nasdaq’s continued listing requirement. Words
such as “will,” “believes,” “intends,” “expects,” “plans,” and similar expressions,
or the use of future tense, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking.
Such forward-looking statements are not guarantees of performance and actual actions or events could differ materially from those contained
in such statements, including, without limitation, risks related to the Company’s ability to regain compliance with Nasdaq’s
continued listing requirements or otherwise maintain compliance with any other listing requirement of The Nasdaq Capital Market, the
potential delisting of the Company’s common stock from The Nasdaq Capital Market due to the Company’s failure to comply with
the applicable rules, the timing of the hearing and the Panel’s decision, which hearing may be scheduled, and such decision may
be issued, more quickly than expected, the outcome of the hearing and the Panel’s decision, and the other risks set forth in the
Company’s filings with the Securities and Exchange Commission. The forward-looking statements contained in this report speak only